Showing results (411-420 of 640) with videos related to

Sort By:
Pageof 64
Natural Product Research|January 30, 2026
Therapeutic effects of wogonin on sepsis and its mechanisms of action: a comprehensive systematic reviewHusni Farah, Waleed K Abdulsahib, Ihsan Khudhair Jasim, et al.
Nanoscale|May 1, 2015
Metal nanocluster light-emitting devices with suppressed parasitic emission and improved efficiency: exploring the impact of photophysical propertiesT-W Koh, A M Hiszpanski, M Sezen, et al.
RSC Advances|April 6, 2026
β-cyclodextrin-functionalized acetylene black nanocomposite electrode with enhanced host-guest enrichment for ultralow-level detection of niclosamideRima Heider Al Omari, Soumya V Menon, Subhashree Ray, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 4, 2025
Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implicationsHussein Salim Abed, N Esanmurodova, Abhinav Kumar, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2015
Synthetic CRISPR RNA-Cas9-guided genome editing in human cellsMeghdad Rahdar, Moira A McMahon, Thazha P Prakash, et al.
Bioorganic & Medicinal Chemistry Letters|August 5, 2018
Activating frataxin expression by single-stranded siRNAs targeting the GAA repeat expansionXiulong Shen, Audrius Kilikevicius, Daniel O'Reilly, et al.
Bioimpacts : BI|June 12, 2026
Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignanciesQamar Abuhassan, Kamel Saleh, S Renuka Jyothi, et al.
Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Antisense properties of 2'-O-dimethylaminooxyethyl (2'-O-DMAOE) oligonucleotidesT P Prakash, A M Kawasaki, J F Johnston, et al.
Journal of Affective Disorders|June 4, 2016
How should we screen for depression following a natural disaster? An ROC approach to post-disaster screening in adolescents and adultsJoseph R Cohen, Zachary W Adams, Suvarna V Menon, et al.
Molecular Therapy. Nucleic Acids|July 24, 2025
Antisense oligonucleotide therapy for patients with Friedreich's ataxia carrying the c.165+5G>C splicing mutationPouiré Yameogo, Selina Aguilar, Thazha P Prakash, et al.
Pageof 64